Connect your AI

InfuSystem Holdings INFU 2031 and thereafter

Other financials

Income statement

Revenue$33.7M-3.0%

Gross profit$19.7M+2.7%

Operating income$1.6M+157%

Net income$1.0M+481%

EPS (diluted)$0.05+600%

Balance sheet

Cash & equivalents$2.1M+39.8%

Total debt$24.1M-30.4%

Total equity$58.7M+6.5%

Total assets$98.7M-5.4%

Cash flow

Operating cash flow$970.0K-45.5%

CapEx$157.0K+19.8%

Free cash flow$813.0K-50.7%

Valuation

Market cap$205.05M+51.3%

Enterprise value$227.04M+36.2%

P/E25.9×-0.8×

P/S1.4×+0.5×

Profitability

Gross margin56.7%+3.6pp

Operating margin9.1%+3.0pp

Net margin5.6%+3.2pp

FCF margin16.2%+1.0pp

Returns & leverage

Return on equity13.9%+8.0pp

Debt / equity0.4×-0.2×

Current ratio2.1×-0.1×

Where this comes from

Reported directly by InfuSystem Holdings in its filing.

Tagged under the XBRL concept infu:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour.

The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InfuSystem Holdings's 2031 and thereafter.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is InfuSystem Holdings's 2031 and thereafter?: InfuSystem Holdings (INFU) reported 2031 and thereafter of $273K in Q1 2026.
How has InfuSystem Holdings's 2031 and thereafter changed year-over-year?: InfuSystem Holdings's 2031 and thereafter decreased by 75.0% year-over-year, from $1.09M to $273K.